PRESS RELEASE published on 05/05/2023 at 11:31, 3 years 2 months ago Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2023
PRESS RELEASE published on 05/05/2023 at 11:31, 3 years 2 months ago Kaufman & Broad SA: DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS 2023
PRESS RELEASE published on 05/04/2023 at 14:18, 3 years 2 months ago Kaufman & Broad SA: MISE EN PAIEMENT DU DIVIDENDE AU TITRE DE L’EXERCICE CLOS LE 30 NOVEMBRE 2022
PRESS RELEASE published on 05/04/2023 at 14:18, 3 years 2 months ago Kaufman & Broad SA: DIVIDEND PAYMENT IN RESPECT OF THE FINANCIAL YEAR ENDED NOVEMBER 30, 2022
PRESS RELEASE published on 04/13/2023 at 18:05, 3 years 3 months ago Kaufman & Broad SA: 1ST QUARTER 2023 RESULTS
PRESS RELEASE published on 04/13/2023 at 18:05, 3 years 3 months ago Kaufman & Broad SA: RESULTATS DU 1ER TRIMESTRE 2023
PRESS RELEASE published on 04/13/2023 at 12:03, 3 years 3 months ago Kaufman & Broad SA: AVAILABILITY OF THE PREPARATORY DOCUMENTS FOR THE COMBINED ORDINARY AND EXTRAORDINARY GENERAL MEETING OF MAY 4, 2023
PRESS RELEASE published on 04/13/2023 at 12:03, 3 years 3 months ago Kaufman & Broad SA: MODALITÉS DE MISE À DISPOSITION DES DOCUMENTS PRÉPARATOIRES AG 2023
PRESS RELEASE published on 03/31/2023 at 17:02, 3 years 3 months ago Kaufman & Broad SA: MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2022
PRESS RELEASE published on 03/31/2023 at 17:02, 3 years 3 months ago Kaufman & Broad SA: AVAILABILITY OF THE 2022 UNIVERSAL REGISTRATION DOCUMENT
Published on 07/22/2026 at 15:00, 1 hour 39 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 1 hour 39 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 2 hours 4 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 2 hours 9 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 15:26, 1 hour 12 minutes ago Chiffres d'Affaires du 1er Trimestre de l'Exercice 2026/2027
Published on 07/22/2026 at 08:03, 8 hours 35 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:03, 8 hours 35 minutes ago Mise à disposition du Rapport Financier Semestriel 2026
Published on 07/22/2026 at 08:00, 8 hours 39 minutes ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
Published on 07/22/2026 at 08:00, 8 hours 39 minutes ago Neoen lance la construction du parc éolien de Narrogin en Western Australia après avoir signé un PPA avec Synergy
